Design, synthesis and structure-activity relationships of mangostin analogs as cytotoxic agents. 2018

Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
State Key Laboratory of Phytochemistry and Plant Resources in West China, Yunnan Key Laboratory of Natural Medicinal Chemistry, Kunming Institute of Botany, Chinese Academy of Sciences Kunming 650201 People' s Republic of China hujiangmiao@mail.kib.ac.cn.

In order to better understand the structure-activity relationship of mangostin, a series of xanthone derivatives based on α-mangostin were designed and synthesized. All the compounds were evaluated for their cytotoxicity against a panel of five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7 and SW480) using MTT assays. Most of them showed cytotoxicity and most of all, compounds 1a and 2h showed the highest cytotoxic potency by HL-60 cancer cell lines with IC50 values of 5.96 μM and 6.90 μM respectively; compound 3e showed the highest cytotoxic potency against SMMC-7221 cancer cell line with IC50 values of 3.98 μM; compounds 2e and 2m showed lower cytotoxicity but higher selectivity than α-mangostin against HL-60 and SMMC-7221 cancer cell lines respectively. Structure-activity relationship analysis indicates that the maintenance of the isopentene group at C-8 is essential for the cytotoxic activity.

UI MeSH Term Description Entries

Related Publications

Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
September 2020, Molecules (Basel, Switzerland),
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
September 2004, Bioorganic & medicinal chemistry letters,
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
September 2013, The Journal of antibiotics,
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
January 2012, Steroids,
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
March 2022, Future medicinal chemistry,
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
August 2009, Journal of medicinal chemistry,
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
February 2010, Bioorganic & medicinal chemistry letters,
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
June 2012, Bioorganic & medicinal chemistry letters,
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
August 2023, Bioorganic & medicinal chemistry,
Xiao-Qian Chi, and Cheng-Ting Zi, and Hong-Mei Li, and Liu Yang, and Yong-Feng Lv, and Jin-Yu Li, and Bo Hou, and Fu-Cai Ren, and Jiang-Miao Hu, and Jun Zhou
March 2011, European journal of medicinal chemistry,
Copied contents to your clipboard!